Is Modern Medical Management Changing Ultimate Patient Outcomes in Inflammatory Bowel Disease?

about

Surgery in Pediatric Crohn's Disease: Indications, Timing and Post-Operative Management.Changing nationwide trends in endoscopic, medical and surgical admissions for inflammatory bowel disease: 2003-2013.

P2860

Q39236482-5B4758E8-73E3-42AB-BF47-276700F8B5D4 Q53833375-A33D31C6-504B-4AB6-9CE3-FF02F4545596

P2860

Is Modern Medical Management Changing Ultimate Patient Outcomes in Inflammatory Bowel Disease?

Item

http://www.wikidata.org/entity/Q38407096

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Is Modern Medical Management C ...... in Inflammatory Bowel Disease?

@en

type

Item

label

Is Modern Medical Management C ...... in Inflammatory Bowel Disease?

@en

prefLabel

Is Modern Medical Management C ...... in Inflammatory Bowel Disease?

@en

P1476

Is Modern Medical Management C ...... in Inflammatory Bowel Disease?

@en

P2093

Alison Althans

http://www.w3.org/2001/XMLSchema#string

Eric K Johnson

http://www.w3.org/2001/XMLSchema#string

Madhuri Nishtala

http://www.w3.org/2001/XMLSchema#string

Quinton M Hatch

http://www.w3.org/2001/XMLSchema#string

Rubina Ratnaparkhi

http://www.w3.org/2001/XMLSchema#string

Ruel Neupane

http://www.w3.org/2001/XMLSchema#string

Scott R Steele

http://www.w3.org/2001/XMLSchema#string

P2860

Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's disease

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

Infliximab for induction and maintenance therapy for ulcerative colitis

Prevalence of childhood and adult obesity in the United States, 2011-2012

Anti-TNF alpha in the treatment of ulcerative colitis: a valid approach for organ-sparing or an expensive option to delay surgery?

Impact of the Medicare Modernization Act of 2003 on utilization and spending for medicare part B-covered biologics in rheumatoid arthritis.

Perioperative anti-tumor necrosis factor therapy does not increase the rate of early postoperative complications in Crohn's disease.

The impact of obesity on outcomes following major surgery for Crohn's disease: an American College of Surgeons National Surgical Quality Improvement Program assessment.

Hospitalisations and surgery in Crohn's disease.

Preoperative use of anti-TNF therapy and postoperative complications in inflammatory bowel diseases: a meta-analysis.

P2888

s11605-016-3275-z

P304

1867-1873

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11605-016-3275-Z

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Michael J. Keating

P577

2016-09-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27634305

http://www.w3.org/2001/XMLSchema#string

P921

inflammatory bowel diseases

Is Modern Medical Management Changing Ultimate Patient Outcomes in Inflammatory Bowel Disease?

about

P2860

P2860

Is Modern Medical Management Changing Ultimate Patient Outcomes in Inflammatory Bowel Disease?

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921